Egis SA

Driven by the rising adoption of biometric fingerprint scanners for accurate identification, faster access, and higher security, the Global Fingerprint Sensor Market is forecasted to cross ~US$ 9 Bn by 2028 says Ken Research Study. GURUGRAM, India, June 28, 2023 /PRNewswire/ -- Fingerprint sensing is one of the prominent access control methods which has gained immense popularity in recent times. The fingerprint sensor belongs to the family of sensors that are used in a fingerprint detection device for authentication and recognition. These sensors are mainly inbuilt into a fingerprint detection module and it is used for the safety of personal computing devices, access, and data. The major features of fingerprint sensors include better performance, accuracy, and validity based on absolute fingerprint biometric technology. According to Ken Research estimates, the Global Fingerprint Sensor Market – which was valued at US$ ~3 Bn in 2017, is estimated to reach the US $5 Bn in 2022 – and is expected to grow further into a more than US$ 9 Bn opportunity by 2028. Ken Research shares 3 key insights on this high opportunity market from its latest research study. 1. Increase in the Adoption of Biometric Fingerprint Sensors has boosted the market. The Global Fingerprint Sensor Market is expected to witness stable growth during the forecast period 2022-2028 primarily due rising adoption of biometric fingerprint scanners for accurate identification, faster access, and higher security. Furthermore, post the COVID-19 pandemic, the Fingerprint Sensor Market gained pace due to increased penetration of smartphones which created better opportunities for new entrants as well as established players in the studied market. Fingerprint sensors have been serving as a primary security phase in smartphones. Even though iris scanners and facial recognition sensors are taking up the pace, their higher cost encourages various enterprises to stick to fingerprint sensing only. Moreover, in certain cases, facial recognition has proven more vulnerable than fingerprint sensing. Interested to Know More about this Report, Request a Free Sample Report 2. The Rising Adoption of Smartphones is Driving the Fingerprint Sensor Market The earliest application of fingerprint sensors in smartphones was by Toshiba in 2011. The adoption of Smartphones is expected to increase to 85% by 2025 from 81% in 202. According to Global System for Mobile Communications Association (GSMA) which is expected to create more opportunities in the studied market. In 2021, Fingerprint Cards AB launchedFPC1553, which is the company's third-generation slim, side-mounted capacitive touch sensor. This is fused in the Honor X40i, Moto g32, and Vivo Y77 smartphones. The FPC1553 is the latest output of their continuous development in the capacitive segment of fingerprint sensors for smartphones. With fingerprint scanners, various banking and government-based mobile applications allow transactions via mobile phone only by authenticating fingerprints. For instance, the Federal Bureau of Investigation (FBI) depends on its partnerships with tribal, state, local, and federal agencies t o collaborate on the development of important programs such as the Next Generation Identification (NGI) systems and the National Crime Information Center (NCIC). 3. High Cost Involved in the Development of Biometric Sensors is Affecting the Fingerprint Sensor Market's growth The growth of the fingerprint sensor market is hampered by several factors that include cost and substitute products. Although fingerprint sensors are used as a primary authentication device in various banking and government facilities, the high cost that is involved in the development of various biometric sensors is challenging to afford for everyone. Hence it affects the market demand globally. The high production cost of raw materials is another important factor that prevents the market growth of the fingerprint Sensors Market Globally. According to Bayometric, a global supplier of fingerprint scanners, single sign-on solutions, and access control systems, on average, fingerprint readers/sensors are priced anywhere from $50-$2,500 each depending on the certifications, brand, type of sensor, etc Visit this Link:- Request for custom report Market Taxonomy By Type Optical Capacitive Thermal Ultrasonic By Application Smartphones/Tablets Laptops Smartcards IoTs Others By End-User Industries Consumer Electronics Travel and Immigration Government and Law Enforcement Military Others Request free 30 minutes analyst call By Region North America USA Canada Mexico Europe Germany UK France Italy Spain Rest of Europe Asia Pacific China Japan India Australia South Korea Rest of Asia Pacific LAMEA Latin America Middle East Africa Key Players Fingerprint Cards AB Egis Technology. Vkansee Technology Inc. Synaptics Apple Inc. CMOS Sensor Inc Goodix Touch Biometrix Q Technology Thales Idemia Qualcomm Technologies, Inc For more insights on market intelligence, refer to the link below: – Global Fingerprint Sensor Market Related Reports by Ken Research Mexico E-commerce Market Outlook to 2027F By Type of Product (Electronics, Fashion, Furniture, Food, Health and personal care, Toys and Others), By Geography (Domestic, Cross-border), By Payment Method (Card, Cash, Bank Transfer, Digital wallet and Others), By Sales Channel (Online, Offline) According to Ken Research estimates, the Mexican e-commerce market – which grew from approximately ~% in 2017 to approximately ~% in 2022P – is forecasted to grow further into ~% opportunity by 2027F. The Mexican E-commerce market contributed to a global growth rate of ~%. The Latin American e-commerce market has recorded robust growth over the last few years, offering exciting opportunities for online retailers across various sectors. International companies seek to increase their global footprint and stake a claim in the expanding Mexican e-commerce industry, increasingly targeting Mexico. Kenya Data Center Market Outlook to 2027F Growing Demand from SMEs, Rising Internet Penetration Rate and Rising Number of Facilities to Drive the Kenyan Data Center market in the near future According to Ken Research estimates, the Kenya Data Center Market – which grew from approximately USD ~30.0 Mn in 2017 to approximately USD ~50.0 Mn in 2022 – is forecasted to grow further into USD ~130.0 Mn opportunity by 2027F, owing to the improvement in network connectivity, government support, and rapid growth in the adoption of big data, and IoT services. Africa Data Centers, is strongly expanding in Nairobi, Kenya by launching new data centers. Kenya has 46 internet users per 100 and the connectivity ecosystem is made up of 10 colocation data centers, and 19 cloud service providers. North America Healthcare Blockchain Market Size, Segments, Outlook, and Revenue Forecast 2022-2027 by Application (Supply Chain Management, Claims and Billing Management, Patient-Centric Health Data, and Others), Deployment (Public, Private, Hybrid, and Consortium), Provider (Infrastructure & Protocol Provider, Middleware Provider, and Application & Solution Provider), End User (Hospitals, Clinics, Diagnostic Laboratories, Pharmaceutical Companies, Medical Device Companies) and Major Countries (USA, Canada, and Mexico) According to Ken Research Analysis, the North America Healthcare Blockchain Market is expected to witness strong growth of around 70% CAGR over the next five years (2022-2027). Security and privacy breaches in the medical industry in 2017 accelerated the demand for the adoption of blockchain in the healthcare sector to reduce risks against cyberattacks and fraud. The ongoing Covid-19 pandemic has benefited the Healthcare Blockchain market resulting in the growth of the overall market by exacerbating the trend toward the adoption of blockchain technology in the healthcare sector. Blockchain in the healthcare sector is not only used for the exchange of the data of patients with hospitals, pharmacy firms, laboratories, and physicians but also helps in improving data security & accuracy, cost reduction, increasing transparency, and tracing of products. India Semiconductor Market Outlook to 2027: Driven by increasing demand by end user industries and increasing adoption for smart devices The market size is expected to grow at a five-year CAGR of ~20% by 2027. With the growing demand by end user industries such as industrial machinery, automobiles, telecommunication equipment, office automation, among others for computing purposes is expected to accelerate the growth of the semiconductor market in the coming years. With internet penetration expected to reach 900 million users in the next few years from 622 million users in 2020, there will be an increasing adoption of smart devices, hence, contributing to the semiconductor market growth. Follow Us – LinkedIn | Instagram | Facebook | Twitter | YouTube Contact Us:- Ken Research Private Limited Ankur Gupta, Director Strategy and Growth [email protected] +91-9015378249 Logo: SOURCE Ken Research

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Rebecca Robertson as Chair of its Board of Directors. Ms. Robertson, who joined Tandem’s Board as an independent director in January 2019, succeeds Kim Blickenstaff, who will continue as a member of the Board. “We’re deeply grateful to Kim for his instrumental contributions to Tandem since 2007, serving first as our CEO then as Chair for the past 4 years,” said John Sheridan, President and Chief Executive Officer. “His strategic vision and mission-driven focus has helped to build and shape Tandem from a venture-backed start-up to a worldwide leader in diabetes care.” “Beckie has added tremendous value to our Board, bringing patient-centric vision and experience with a range of technologies and business models,” said Kim Blickenstaff. “She was a natural choice for this position at an exciting juncture in our evolution, and I am confident that with her leadership, we will continue expanding our global reach and delivering positively different innovation for the diabetes community.” “I am honored to be named Chair and am committed to maximizing the opportunities we have at Tandem,” said Ms. Robertson. “Tandem continues to deliver life-changing solutions to people around the world and has a compelling pipeline of products in development that offer near and long-term growth potential. I believe our technology can change the face of therapy for people with diabetes and I’m excited to be part of what comes next.” Ms. Robertson has an impressive track record of helping medical device companies scale in her roles as an engineer, entrepreneur, corporate executive and board member. She is a founder and General Partner at Versant Ventures where she has specialized in investing in the areas of medical devices and diagnostics since 1999. In addition, through Longridge Business Advisors, she has provided business advisory services and board services since April 2017. Prior to Versant, she served as Senior Vice President at Chiron Diagnostics, a division of Chiron Corporation, where she had responsibility for the critical care business unit in addition to leading the division’s business development efforts. Prior to joining Chiron, Ms. Robertson was a co-founder and Vice President at Egis, a consumer products company, and held senior management positions in operations and finance at Lifescan, a Johnson & Johnson Company. Ms. Robertson holds a BS in Chemical Engineering from Cornell University. About Tandem Diabetes Care, Inc. Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The Company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. For more information, visit tandemdiabetes.com. Tandem Diabetes Care and Control-IQ are trademarks registered in the U.S. and/or other countries and t:slim X2 is a trademark of Tandem Diabetes Care, Inc. Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2 and $TNDM. Follow Tandem Diabetes Care on Facebook at . Follow Tandem Diabetes Care on LinkedIn at . Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that concern matters that involve risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in the forward-looking statements. These forward-looking statements include statements regarding, among other things, the Company’s future growth. The Company’s actual results may differ materially from those indicated in these forward-looking statements due to numerous risks and uncertainties. For instance, the Company’s ability to achieve projected financial results will be impacted by market acceptance of the Company’s existing products and products under development by physicians and people with diabetes; the Company’s ability to establish and sustain operations to support international sales, including expansion into additional geographies; changes in reimbursement rates or insurance coverage for the Company’s products; the Company’s ability to meet increasing operational and infrastructure requirements from higher customer interest and a larger base of existing customers; the Company’s ability to complete the development and launch of new products when anticipated; the potential that newer products, or other technological breakthroughs for the monitoring, treatment or prevention of diabetes, may render the Company’s products obsolete or less desirable; the depth and duration of the COVID-19 pandemic, and the global response thereto; reliance on third-party relationships, such as outsourcing and supplier arrangements; global economic conditions; and other risks identified in the Company’s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and other documents that the Company files with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Tandem undertakes no obligation to update or review any forward-looking statement in this press release because of new information, future events or other factors. View source version on businesswire.com: Contacts Investor Contact: 858-366-6900 IR@tandemdiabetes.com Source: Tandem Diabetes Care, Inc. View this news release online at: